{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:26:28Z","timestamp":1772756788101,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTCHD"],"published-print":{"date-parts":[[2002,6,1]]},"DOI":"10.2174\/1568006023337745","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T00:24:16Z","timestamp":1111710256000},"page":"43-52","source":"Crossref","is-referenced-by-count":27,"title":["Trypanosoma cruzi Trypanothione Reductase Inhibitors: Phenothiazines and Related Compounds Modify Experimental Chagas\u00b4 Disease Evolution"],"prefix":"10.2174","volume":"2","author":[{"family":"H.W. Rivarola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"P.A. Paglini-Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Target -Cardiovascular & Hematological Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/92148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T20:21:21Z","timestamp":1547929281000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/node\/92148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568006023337745","relation":{},"ISSN":["1568-0061"],"issn-type":[{"value":"1568-0061","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6,1]]}}}